Inventor · disambiguated record
Al Kaller
Also filed as: KALLER AL
18 granted patents·6 pending applications·409 citations·filing 2000–2022
95Inventor score
Top patents by PatentIndex Score
24 records- 0196US7863293B2CXCR4 chemokine receptor binding compoundsGENZYME CORP·Filed 2007·Granted Jan 4, 2011·24 cites·18 claims
- 0295US7291631B2CXCR4 chemokine receptor binding compoundsGENZYME CORP·Filed 2004·Granted Nov 6, 2007·50 cites·25 claims
- 0394US7354934B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyANORMED INC·Filed 2005·Granted Apr 8, 2008·34 cites·10 claims
- 0494US6864265B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted Mar 8, 2005·42 cites·6 claims
- 0594US6750348B1Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2000·Granted Jun 15, 2004·61 cites·30 claims
- 0693US7091217B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2004·Granted Aug 15, 2006·31 cites·12 claims
- 0793US6835731B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted Dec 28, 2004·53 cites·10 claims
- 0893US6734191B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2001·Granted May 11, 2004·35 cites·15 claims
- 0990US7354932B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyANORMED INC·Filed 2003·Granted Apr 8, 2008·27 cites·21 claims
- 1089US8778967B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyBRIDGER GARY·Filed 2012·Granted Jul 15, 2014·18 cites·20 claims
- 1184US7550484B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2004·Granted Jun 23, 2009·19 cites·11 claims
- 1276US7396840B2Chemokine receptor binding heterocyclic compoundsGENZYME CORP·Filed 2006·Granted Jul 8, 2008·1 cites·9 claims
- 1375US10322111B2Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2016·Granted Jun 18, 2019·1 cites·13 claims
- 1475US7312234B2Chemokine receptor binding heterocyclic compoundsANORMED·Filed 2004·Granted Dec 25, 2007·7 cites·6 claims
- 1573US7629337B2Chemokine receptor binding heterocyclic compoundsGENZYME CORP·Filed 2006·Granted Dec 8, 2009·1 cites·9 claims
- 1669US7084155B2Chemokine receptor binding heterocyclic compoundsANORMED·Filed 2004·Granted Aug 1, 2006·3 cites·15 claims
- 1767US7183273B2Chemokine receptor binding heterocyclic compoundsANORMED INC·Filed 2004·Granted Feb 27, 2007·2 cites·10 claims
- 1867US2020000774A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2019·Application pending·0 cites
- 1963US2015038509A1Chemokine Receptor Binding Heterocyclic Compounds With Enhanced EfficacyGENZYME CORP·Filed 2014·Application pending·0 cites
- 2062US7807694B2Chemokine receptor binding heterocyclic compoundsGENZYME CORP·Filed 2006·Granted Oct 5, 2010·0 cites·4 claims
- 2162US2008167341A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyBRIDGER GARY·Filed 2008·Application pending·0 cites
- 2259US2009281308A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyBRIDGER GARY J·Filed 2009·Application pending·0 cites
- 2359US2022409589A1Chemokine receptor binding heterocyclic compounds with enhanced efficacyGENZYME CORP·Filed 2022·Application pending·0 cites
- 2457US2008090846A1Chemokine receptor binding heterocyclic compoundsBRIDGER GARY·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Al Kaller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →